BioMarin Pharmaceutical Inc.

Healthcare · Biotechnology · United States

Last price 58.51 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.33B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company’s products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NA...